CHRYSTELL CLUCK: Open Payments
NPI 1326514787 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$507 in 13 payments from 9 companies in 2025. Trend: 2023 $1,269 · 2024 $638 · 2025 $507
Food & beverage: $407Education: $100
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $138 |
| Janssen Biotech, Inc. | 2 | $120 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $95 |
| ABBVIE INC. | 2 | $59 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| GENZYME CORPORATION | 1 | $23 |
| Galderma Laboratories, L.P. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| Organon LLC | 1 | $4 |
Products named: EBGLYSS, TREMFYA, RINVOQ, Sotyktu, SKYRIZI, DUPIXENT, NEMLUVIO, COSENTYX.
Industry payments across NC — which companies pay providers there.
